Cancer Research UK logo.
SearchDonate
  • Search

A trial of enobosarm for women with early breast cancer (EMERALD)

Overview

Cancer types:

Breast cancer

Status:

Closed

Phase:

Phase 2

Details

This trial is for women with hormone receptor positive breast cancer who are going to have surgery. Hormone receptor positive means that cancer cells respond to changes in the levels of:

It is for women who can no longer become pregnant ().

Cancer Research UK supports this trial.

Recruitment start: 27 June 2017

Recruitment end: 19 October 2018

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor Carlo Palmieri

Supported by

Cancer Research UK

GTx, Inc

Liverpool Cancer Trials Unit

University of Liverpool

Other information

This is Cancer Research UK trial number CRUK/15/075

Last reviewed: 22 December 2022

CRUK internal database number: 13389

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.